From genes to public health: The applications of genetic technology in disease prevention

被引:90
作者
Khoury, MJ
Adams, M
Brown, V
Chen, ATL
Erickson, JD
Hannon, W
Mei, J
Moore, C
Mueller, P
Oakley, G
Olney, R
Ou, CY
Reidy, JA
Steinberg, K
Whitehead, N
Anda, RF
Ballew, C
Croft, JB
Giles, WH
Janes, G
Kendrick, J
Lee, NC
Eberhardt, M
McQuillan, G
Wagener, D
McNicholl, J
Rickles, F
Schulte, P
机构
[1] Centers for Dis. Contr./Prevention, Atlanta
[2] Birth Defects/Genet. Diseases Branch, Natl. Ctr. for Environmental Health, Centers for Dis. Contr./Prevention, Atlanta
关键词
D O I
10.2105/AJPH.86.12.1717
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. With advances in the Human Genome Project, the implications of genetic technology in disease prevention should be assessed. Methods. The paradigm suggested in The Future of Public Health-assessment, policy development, and assurance-was used to examine the continuum from genetic technology to public health practice. Results. First, important public health functions are to (1) assess the impact of genes and their interactions with modifiable disease risk factors on the health status of the population and (2) assess the impact and safety of genetic testing on the population. Second, given the many implications of genetic testing, the public health community should participate in policy development related to the timing and use of genetic testing in disease prevention. Third, whenever appropriate, the public health community needs to ensure the development of public health generics programs (e.g. newborn screening) and evaluate the quality and effectiveness of the use of genetic testing in disease prevention. Conclusions Although most current genetic tests are not ready for disease prevention, there is an important role for the public health community in translating genetic technology into disease prevention.
引用
收藏
页码:1717 / 1722
页数:6
相关论文
共 58 条
  • [1] ANDREWS LB, 1991, AM J LAW MED, V17, P75
  • [2] [Anonymous], 1993, Exploding the gene myth
  • [3] [Anonymous], 1992, Morbidity and mortality weekly report
  • [4] [Anonymous], PROCEED CAUTION PRED
  • [5] [Anonymous], 1992, MENDELIAN INHERITANC
  • [6] EPIDEMIOLOGY OF HIV INFECTION AND AIDS
    BERKELMAN, RL
    CURRAN, JW
    [J]. EPIDEMIOLOGIC REVIEWS, 1989, 11 : 222 - 228
  • [7] GENETIC TESTING IN THE WORKPLACE - A VIEW FROM THE USA
    BILLINGS, P
    BECKWITH, J
    [J]. TRENDS IN GENETICS, 1992, 8 (06) : 198 - 202
  • [8] THE GENETIC-ANALYSIS OF HUMAN-BEHAVIOR - A NEW ERA
    BILLINGS, PR
    BECKWITH, J
    ALPER, JS
    [J]. SOCIAL SCIENCE & MEDICINE, 1992, 35 (03) : 227 - 238
  • [9] CHILDS B, 1988, MOL GENET METAB, P180
  • [10] STATEMENT ON USE OF DNA TESTING FOR PRESYMPTOMATIC IDENTIFICATION OF CANCER RISK
    COLLINS, FS
    BENJAMIN, LJ
    BOTSTEIN, D
    COX, JR
    DAVIDSON, N
    GRAY, JW
    HOLTZMAN, N
    HOUSMAN, DE
    JAMISON, KR
    NELKIN, D
    ROTHSTEIN, R
    SMITH, DC
    SMITH, LM
    SPENCE, MA
    TILGHMAN, SM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (10): : 785 - 785